Engage / Grants / Longevity Biotechnology Grant

Longevity Biotechnology Grant

We provide small fast grants to visionary scientists and entrepreneurs working on groundbreaking innovations in longevity biotechnology. These grants are designed to quickly support and launch new ideas and projects, acting as a financial launchpad that de-risks early-stage projects often overlooked by legacy funders.

Focus Areas

 

  • AI R&D: accelerating scientific discovery, research, and lab work through the application of AI, Digital Twin models, and automation tools.
  • Extra cellular matrix (ECM): maintaining or improving ECM health for healthy aging.
  • Exosomes: exosomes for tissue repair, drug delivery, and other longevity interventions.
  • Gene therapy: developing scalable gene therapy vectors and pioneering novel delivery vehicles.
  • Healthcare 3.0: advancing biomarker analysis and scalable personal longevity approaches.
  • Reversible biostasis: pioneering new approaches to reversible biological preservation.
  • Replacement: developing organ, brain, 3D organoid technology, and whole body replacement approaches.
  • Mapping novel opportunities: proposals that map and scope novel, undervalued opportunities within a given field.

Fast grant: longevity biotechnology

Longevity biotechnology has the potential to stop aging, diminish age-related diseases like cancer and heart disease, and extend healthy lives. To accelerate progress, we offer fast grants – smaller and with short review times – to quickly test promising ideas. Our focus is on projects that can help achieve longevity escape velocity (LEV) – improving life expectancy at a faster rate than people are aging.

Healthcare that is focused on preventing and reversing aging would not only diminish the pains of age-related disease, but also enable people to live healthy lives for as long as they choose. We also see functional cryonics as an alternative path toward that same goal.

Focus areas

Areas we fund include but are not limited to:

These focus areas are influenced by Convergent Research’s Gap Map, the Amaranth’s Bottlenecks of Aging Roadmap and the LBF Roadmap.

How to apply?

Fill out the form at the top of this page to apply. Applications are reviewed once per quarter, with deadlines of:

We work to keep the review process efficient and minimal. If required, we may follow up with questions or arrange a brief screening call.

Funding and terms

How do we evaluate projects?

Projects are evaluated by Foresight staff and, when appropriate, external advisors. Our focus is on high-risk, high-reward projects that, while speculative, hold the potential to make significant advancements.

Further questions or feedback?

Please reach out to [email protected]

About fast grants

Traditional funding often overlook early-stage, high-potential projects. Inspired by the fast grants model pioneered by Impetus Grants, our aim with these grants is to change that. Many projects require as little as $10,000 to get started, yet they often fall outside the strict topical or operational criteria of traditional funders. Just as importantly, timely action is critical: promising ideas are too often delayed by lengthy application procedures and bureaucratic hurdles. Our grants exist to remove these barriers and help new projects launch quickly.

Advisors

Adrian Matysek

Sabatini Lab

Alexander Fedintsev

Radical Life Extension group

Christine Peterson

Foresight Institute

Elena Sergeeva

Wyss Institute

Guido Putignano

ETH Zurich

John Hallman

OpenAI

Kai Micah Mills

CEO of Cryopets

Karl Pfleger

Agingbiotech.info

Mark Hamalainen

ARPA-H

Michael Florea

Olden Labs

Nikola T. Markov

Buck Institute for Research on Aging

Philip Shiu

Eon Systems PBC

Reason

Fight Aging

Rico Meinl

Retro Biosciences

Roman Bauer

University of Surrey

Sonia Arrison

100 Plus Capital

Sruthi Sivakumar

Retro Biosciences

Varun Dwaraka

TruDiagnostic

Yuri Deigin

Co-Founder of YouthBio Therapeutics

Made possible by

In addition to our private contributors, we would like to thank the following sponsors for making this grant possible.

Fund the science of the future.

Donate today